Newly Launched Products

Established in 2007 with a capital of 50 lakhs, STAY WELL has now become a leading pharma-ceutical company of India with a goal to help patients lead healthier lives through two parallel objectives: formulating, developing and commercializing medicines; & delivering affordable and accessible medication that satisfy urgent medical needs to all.

News And Events

In Pivotal Phase III Studies, Merck's Investigational Medicine Boceprevir Helped Majority of Patients with Chronic Hepatitis C Genotype 1 Infection Achieve Sustained Virologic Response, the Primary Endpoint of the Studies

Quick Contact
Name:
E-Mail:
Contact NO.
Query:
copyright @ staywell 2010
home      |     about us    |    gallery     |     product     |    Carrer     |    contact us